Stay updated on ATI-450 Plus MTX in RA Clinical Trial

Sign up to get notified when there's something new on the ATI-450 Plus MTX in RA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ATI-450 Plus MTX in RA Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Removed a general notice about potential delays and government operating status due to funding, including references to cc.nih.gov and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:33:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added related topics links for Rheumatoid Arthritis and MedlinePlus Genetics on the Study Details page.
    Difference
    0.1%
    Check dated 2025-11-10T14:57:34.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page between the two screenshots. The study record NCT05279417, including ATI-450 plus MTX versus placebo plus MTX, remains unchanged in key sections such as the study design, interventions, eligibility criteria, and outcomes.
    Difference
    0.3%
    Check dated 2025-11-03T12:25:17.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added related topics: Rheumatoid arthritis and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-27T08:44:30.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Summary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T17:21:07.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.5%
    Check dated 2025-09-28T10:13:00.000Z thumbnail image

Stay in the know with updates to ATI-450 Plus MTX in RA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ATI-450 Plus MTX in RA Clinical Trial page.